The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.

Firms / M•• P••••••• L••

M•• P••••••• L••

Institutional venture firmLondonm••.comSEC venture capital fund adviser

MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.

venture manager, reported GAV $1,222M across 14 vehicles

Importance
46
elevated
Active deployment
33
moderate
Emerging
0
low
Completeness
69
high
Freshness
98
high
Research priority
16
moderate
Identity and regulatory footprint
Headquarters
Boston, MAadviserinfo.sec.gov
Office address
OLD CITY HALL, 45 SCHOOL STREET, Boston, MA, 02108adviserinfo.sec.gov
Business phone
1 617 383 2101adviserinfo.sec.gov
Website
m••.com
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Jun 29, 2026
Private funds reported
10 (10 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$1.0Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
M•• ••• •••••• L•••••• (Manager), NA
business phone
44 20 7557 7500adviserinfo.sec.govpublished by the subject
business phone
1 617 383 2101adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
2 observed deals
Stated (the firm’s website)
Sectors
healthcare, biotech, medtech, crypto, industrial, media
Stages
not stated or not yet read
Geography
boston, global
Check size
$20.0M to $100M stated by the firm
“We expect to make aggregate investments of $20 to 100 million in each of our portfolio companies over our holding period.”
Observed (from deals on record)
Stage at participation
series c 50%series d plus 50%
Stage at first entry
series c 50%series d plus 50%
Sectors
unknown 50%Other Health Care 50%
lead rate 50%follow-on rate 0%new logos, 12 months 2
Funds and vehicles
14 reported, 2 no longer reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
M•• F• L•Fund2024 adv first reportedEarly deployment$3.0M
Jun 27, 2024
2$0Dec 16, 2022
M•• D• L•Fund2023 adv first reportedActive deployment$11.1M
Jun 27, 2024
6$0Dec 16, 2022
M•• V• L•Fund2022 form d first saleActive deployment$487M
Jun 27, 2024
89$260MNov 10, 2022
M•• C• L•Fund2022 form d first saleActive deployment$14.5M
Jun 27, 2024
16$7.5MDec 16, 2022
M•• a• L•Fund2022 form d first saleActive deployment$14.2M
Jun 27, 2024
9$6.5MDec 16, 2022
M•• V• ••••• L•Fund2021 name yearMature$30.7M
Jun 27, 2024
16$11.6MDec 16, 2022
M•• V• ••••• L•Fund2020 name yearMature$66.1M
Jun 27, 2024
12$46.5MDec 16, 2022
M•• I•• ••••• L•Fund2020 name yearMature$8.0M
Jun 27, 2024
4$4.3MDec 16, 2022
M•• I• ••••• L•Fund2019 name yearMature$10.4M
Jun 27, 2024
3unknownunknown
M•• V• L•Fund2018 form d first saleHarvest$356M
Jun 27, 2024
64$142M
of $300M
Oct 15, 2018
M•• I• C••••••••• I• L•SPV or co-invest vehicle2015 adv first reportedHarvest$3.5M
Jun 27, 2024
3unknownunknown
M•• I• L•Fund2014 form d first saleHarvest$192M
Jun 27, 2024
24$27.0MApr 21, 2015
M•• F••• I•• L•••••• P•••••••••FundunknownUnknown$23.8M
Jun 27, 2024
26unknownunknown
M•• F••• I•• ••••• L•••••• P•••••••••FundunknownUnknown$1.2M
Jun 27, 2024
3unknownunknown
M•• I••••••••• L••• S••••••• N••• L•••••• P•••••••••FundunknownWound down$9.5M
Aug 8, 2017
21unknownunknown
U• M•••••• V••••••• F••• N•• 1• L•••••• P•••••••••FundunknownWound down$5.3M
Aug 8, 2017
11unknownunknown
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
13 current, 5 departed
Founder or executive
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
E••• B••••••••
Member · since Mar 1, 2008
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
K•••• X• C••••
Member · since Jan 1, 2021
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
K•••• X• C••••
Member · since Jan 1, 2021
Partner
FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
Partner
FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
E••• B••••••••
Treasurer · since Dec 1, 2015
Platform and operations
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
5 departed (kept with end dates)
Investments on record
2 edges, 2 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
G• M•••••• T••••••••• I•••Series E · Series D+participantunknown$100MunknownJun 9, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
N•••••• M••••••Series C · Series CleadunknownunknownunknownFeb 11, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
8 relationships from shared deals, counted for the whole firm
Medtech Venture Partners 1 shared · one timeEvidity Capital LLC 1 shared · one timeGilde Healthcare 1 shared · one timeFemhealth Ventures Management LLC 1 shared · one timeEnterprise Ireland 1 shared · one time · we led 1Fountain Healthcare Partners 1 shared · one time · we led 1L••• S••••••• 1 shared · one time · we led 1Atlantic Bridge 1 shared · one time · we led 1
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
39 dated events
  1. Jun 29, 2026
    5 of 11 people on M•• P••••••• L••'s 2024 Schedule A are no longer printed on its 2026-06-29 filing
    Schedule a restructuredPeopleFactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
  2. Jun 27, 2024
    M•• F• L• first reported on Form ADV by M•• P•••••••, LLC (Venture Capital Fund), GAV $3,030,000
    Fund first reported on Form ADVFundsFactM•• F• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Apr 1, 2024
    A•• I••••••• M•••• joined Schedule A of M•• P••••••• L•• as Member
    Person joinedPeopleFactA•• I••••••• M••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  4. Jul 3, 2023
    M•• D• L• first reported on Form ADV by M•• P•••••••, LLC (Venture Capital Fund), GAV $11,097,675
    Fund first reported on Form ADVFundsFactM•• D• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  5. Jul 3, 2023
    M•• V• L• first reported on Form ADV by M•• P•••••••, LLC (Venture Capital Fund), GAV $502,148,338
    Fund first reported on Form ADVFundsFactM•• V• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  6. Jul 3, 2023
    M•• a• L• first reported on Form ADV by M•• P•••••••, LLC (Venture Capital Fund), GAV $11,826,531
    Fund first reported on Form ADVFundsFactM•• a• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  7. Jul 3, 2023
    M•• C• L• first reported on Form ADV by M•• P•••••••, LLC (Venture Capital Fund), GAV $16,228,244
    Fund first reported on Form ADVFundsFactM•• C• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  8. Jun 30, 2023
    M•• V• ••••• L• no longer reported on Form ADV by M•• P••••••• L••
    Fund no longer reportedFundsInferenceM•• V• ••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  9. Jun 30, 2023
    M•• V• L• no longer reported on Form ADV by M•• P••••••• L••
    Fund no longer reportedFundsInferenceM•• V• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  10. Jun 30, 2023
    M•• I•• ••••• L• no longer reported on Form ADV by M•• P••••••• L••
    Fund no longer reportedFundsInferenceM•• I•• ••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  11. Jun 30, 2023
    M•• V• ••••• L• no longer reported on Form ADV by M•• P••••••• L••
    Fund no longer reportedFundsInferenceM•• V• ••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  12. Jun 30, 2022
    M•• V• ••••• L• first reported on Form ADV by M•• P••••••• L•• (Venture Capital Fund), GAV $24,446,773
    Fund first reported on Form ADVFundsFactM•• V• ••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  13. Jun 28, 2021
    M•• I• ••••• L• first reported on Form ADV by M•• P••••••• L•• (Venture Capital Fund), GAV $5,229,750
    Fund first reported on Form ADVFundsFactM•• I• ••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  14. Jun 28, 2021
    M•• V• ••••• L• first reported on Form ADV by M•• P••••••• L•• (Venture Capital Fund), GAV $85,446,519
    Fund first reported on Form ADVFundsFactM•• V• ••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  15. Jun 28, 2021
    M•• I•• ••••• L• first reported on Form ADV by M•• P••••••• L•• (Venture Capital Fund), GAV $9,747,876
    Fund first reported on Form ADVFundsFactM•• I•• ••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  16. Jan 1, 2021
    K••• E••••• D•••••• joined Schedule A of M•• P•••••••, LLC as Member
    Person joinedPeopleFactK••• E••••• D••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  17. Jan 1, 2021
    K•••• X• C•••• joined Schedule A of M•• P•••••••, LLC as Member
    Person joinedPeopleFactK•••• X• C••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  18. Nov 1, 2020
    J••• Y•••• T••••• joined Schedule A of M•• P••••••• L•• as Member
    Person joinedPeopleFactJ••• Y•••• T•••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  19. Jun 24, 2019
    B••••• M••••••••• (Member) no longer on Schedule A of M•• P••••••• L••
    Person leftPeopleInferenceB••••• M•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  20. Jun 24, 2019
    N••• K•••• S•••• (Member) no longer on Schedule A of M•• P••••••• L••
    Person leftPeopleInferenceN••• K•••• S••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  21. Jun 24, 2019
    M•• V• L• first reported on Form ADV by M•• P••••••• L•• (Venture Capital Fund), GAV $237,727,273
    Fund first reported on Form ADVFundsFactM•• V• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  22. Sep 1, 2018
    K••• E••••• D•••••• joined Schedule A of M•• P••••••• L•• as Member
    Person joinedPeopleFactK••• E••••• D••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  23. Jun 27, 2018
    U• M•••••• V••••••• F••• N•• 1• L•••••• P••••••••• no longer reported on Form ADV by M•• P••••••• L••
    Fund no longer reportedFundsInferenceU• M•••••• V••••••• F••• N•• 1• L•••••• P•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  24. Jun 27, 2018
    M•• I••••••••• L••• S••••••• N••• L•••••• P••••••••• no longer reported on Form ADV by M•• P••••••• L••
    Fund no longer reportedFundsInferenceM•• I••••••••• L••• S••••••• N••• L•••••• P•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  25. Dec 1, 2016
    N••• K•••• S•••• joined Schedule A of MVM L••• Science Partners as Member
    Person joinedPeopleFactN••• K•••• S••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  26. Nov 1, 2016
    K•••• X• C•••• joined Schedule A of MVM L••• Science Partners as Member
    Person joinedPeopleFactK•••• X• C••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  27. Nov 13, 2015
    B•••• S••• H•• (Member) no longer on Schedule A of MVM L••• Science Partners
    Person leftPeopleInferenceB•••• S••• H••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  28. Jun 24, 2015
    M•• I• C••••••••• I• L• first reported on Form ADV by MVM L••• Science Partners (Venture Capital Fund), GAV $10,454,403
    Fund first reported on Form ADVFundsFactM•• I• C••••••••• I• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  29. Oct 1, 2014
    M•• I• L• first reported on Form ADV by MVM L••• Science Partners (Venture Capital Fund), GAV $105,500,000
    Fund first reported on Form ADVFundsFactM•• I• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  30. Nov 1, 2012
    B••••• M••••••••• joined Schedule A of MVM L••• Science Partners as Member
    Person joinedPeopleFactB••••• M•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  31. Oct 16, 2012
    A•••••••• T••••• P•••••• (Member) no longer on Schedule A of MVM L••• Science Partners
    Person leftPeopleInferenceA•••••••• T••••• P••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  32. May 25, 2012
    M••••• P•••••• M••••• (Member) no longer on Schedule A of MVM L••• Science Partners
    Person leftPeopleInferenceM••••• P•••••• M•••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  33. May 25, 2012
    M••••• P•••••• M••••• (Member) no longer on Schedule A of MVM L••• Science Partners
    Person leftPeopleInferenceM••••• P•••••• M•••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  34. Mar 27, 2012
    MVM L••• Science Partners first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  35. Mar 19, 2012
    M•• I••••••••• L••• S••••••• N••• L•••••• P••••••••• first reported on Form ADV by MVM L••• Science Partners (Venture Capital Fund), GAV $142,574,796
    Fund first reported on Form ADVFundsFactM•• I••••••••• L••• S••••••• N••• L•••••• P•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  36. Mar 19, 2012
    U• M•••••• V••••••• F••• N•• 1• L•••••• P••••••••• first reported on Form ADV by MVM L••• Science Partners (Venture Capital Fund), GAV $17,907,928
    Fund first reported on Form ADVFundsFactU• M•••••• V••••••• F••• N•• 1• L•••••• P•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  37. Mar 19, 2012
    M•• F••• I•• L•••••• P••••••••• first reported on Form ADV by MVM L••• Science Partners (Venture Capital Fund), GAV $183,221,828
    Fund first reported on Form ADVFundsFactM•• F••• I•• L•••••• P•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  38. Mar 19, 2012
    M•• F••• I•• ••••• L•••••• P••••••••• first reported on Form ADV by MVM L••• Science Partners (Venture Capital Fund), GAV $9,043,396
    Fund first reported on Form ADVFundsFactM•• F••• I•• ••••• L•••••• P•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  39. Mar 19, 2012
    MVM L••• Science Partners first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $1,222M across 14 vehicles
Evidence
94 observations from 4 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedJun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserJun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC exemption claimedventure_capital_fund_adviserJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserJun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-03-19Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-03-27Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-06-29Jun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-06-27Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-06-27Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveJun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2012-03-27Jun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone1 617 383 2101Jun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone44 20 7557 7500Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone1 617 383 2101Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
DescriptionMVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
“meta description”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionMVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
“meta description”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersBoston, MAJun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersLondon, United KingdomJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersBoston, MAJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office addressOLD CITY HALL, 45 SCHOOL STREET, Boston, MA, 02108Jun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address38 WIGMORE STREET, 4TH FLOOR, SUITE 2, London, W1U 2RUJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office addressOLD CITY HALL, 45 SCHOOL STREET, Boston, MA, 02108Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formL•••••• Liability CompanyJun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formL•••••• Liability P•••••••••Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formL•••••• Liability CompanyJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported10Jun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported5Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported9Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$1.0BJun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$231MJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$991MJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Schedule a diffsadiff-1Jun 29, 2026FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
Stated check (high)$100M
“We expect to make aggregate investments of $20 to 100 million in each of our portfolio companies over our holding period.”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated check (high)$100M
“We expect to make aggregate investments of $20 to 100 million in each of our portfolio companies over our holding period.”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated check (low)$20.0M
“We expect to make aggregate investments of $20 to 100 million in each of our portfolio companies over our holding period.”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated check (low)$20.0M
“We expect to make aggregate investments of $20 to 100 million in each of our portfolio companies over our holding period.”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyboston,global
“geography words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyboston,global
“geography words on the home page”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,biotech,medtech,crypto,industrial,media
“sector words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,biotech,medtech,crypto,industrial,media
“sector words on the home page”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported10Jun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported5Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture funds reported9Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://m••.com/Jun 29, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
WebsiteHTTP://w••.m••.comJun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://m••.com/Jun 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleM•• P••••••• L•• | M•• P••••••• L••
“title tag”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleM•• P••••••• L•• | M•• P••••••• L••
“title tag”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)